Sonnet BioTherapeutics Holdings - stock earnings
SONN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.2 million USD | 18626 USD |
| 2023Q3 | -3.7 million USD | 37255 USD |
| 2023Q2 | -3.9 million USD | 36850 USD |
| 2023Q1 | -5.7 million USD | 36445 USD |
| 2022Q4 | -5.5 million USD | 37255 USD |
| 2022Q3 | -7.5 million USD | 62753 USD |
| 2022Q2 | -7.9 million USD | 62071 USD |
| 2022Q1 | -8.2 million USD | 95320 USD |
| 2021Q4 | -6.2 million USD | 129799 USD |
| 2021Q3 | -7.0 million USD | 483626 USD |
| 2021Q2 | -6.1 million USD | ? USD |
| 2021Q1 | -6.0 million USD | ? USD |
| 2020Q4 | -5.9 million USD | ? USD |
| 2020Q3 | -7.5 million USD | -5.7 million USD |
| 2020Q2 | -11.8 million USD | ? USD |
| 2020Q1 | -1.9 million USD | 5.7 million USD |
| 2019Q4 | -2.5 million USD | -418865 USD |
| 2019Q3 | -3.9 million USD | 9.7 million USD |
| 2019Q2 | -3.2 million USD | 10.7 million USD |
| 2019Q1 | -2.3 million USD | 10.1 million USD |
| 2018Q4 | -2.3 million USD | 10.1 million USD |
| 2018Q3 | -1.7 million USD | 10.1 million USD |
| 2018Q2 | -732668 USD | 10.4 million USD |
| 2018Q1 | -3.4 million USD | 10.0 million USD |
| 2017Q4 | -2.1 million USD | 10.1 million USD |
| 2017Q3 | -1.6 million USD | 10.7 million USD |
| 2017Q2 | -1.4 million USD | 10.8 million USD |
| 2017Q1 | -1.7 million USD | 9.9 million USD |
| 2016Q4 | -1.8 million USD | 9.9 million USD |
| 2016Q3 | -904017 USD | 11.0 million USD |
| 2016Q2 | -5.1 million USD | 10.8 million USD |
| 2016Q1 | -2.4 million USD | 12.7 million USD |
| 2015Q4 | -2.4 million USD | 12.7 million USD |
| 2015Q3 | -4.5 million USD | 10.3 million USD |
| 2015Q2 | -2.9 million USD | 10.8 million USD |
| 2015Q1 | -2.3 million USD | 8.7 million USD |
| 2014Q4 | -3.0 million USD | 7.7 million USD |
| 2014Q3 | -551440 USD | 9.6 million USD |
| 2014Q2 | -1.4 million USD | 6.9 million USD |
| 2014Q1 | -1.5 million USD | 5.6 million USD |
| 2013Q4 | -2.3 million USD | 3.3 million USD |
| 2013Q3 | -1.5 million USD | 1.6 million USD |
| 2013Q2 | -706934 USD | 1.7 million USD |
| 2013Q1 | -771642 USD | 1.7 million USD |
| 2012Q4 | 1.1 million USD | -35343 USD |
| 2012Q3 | -739766 USD | 1.8 million USD |
| 2012Q2 | -733381 USD | 1.7 million USD |
| 2012Q1 | -703785 USD | ? USD |
| 2011Q4 | -515528 USD | -351199 USD |
| 2011Q3 | -495757 USD | 25000 USD |
| 2011Q2 | -280 USD | 441667 USD |
| 2009Q1 | -93953 USD | ? USD |
| 2006Q3 | -83960 USD | ? USD |
SONN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -18.8 million USD | 147805 USD |
| 2022 | -29.8 million USD | 349943 USD |
| 2021 | -25.0 million USD | 483626 USD |
| 2020 | -31.1 million USD | ? USD |
| 2019 | -5.0 million USD | 40.6 million USD |
| 2018 | -6.9 million USD | 30.7 million USD |
| 2017 | -6.8 million USD | 41.4 million USD |
| 2016 | -9.1 million USD | 41.7 million USD |
| 2015 | -12.1 million USD | 42.4 million USD |
| 2014 | -6.4 million USD | 29.8 million USD |
| 2013 | -6.0 million USD | 17.5 million USD |
| 2012 | -1.0 million USD | 115468 USD |
| 2011 | -1.0 million USD | 115468 USD |
SONN
Price: $1.76
52 week price:
Earnings Per Share: -0.83 USD
P/E Ratio: -0.08
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 442053
Market Capitalization: 5.8 million